BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1682038)

  • 1. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
    Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA
    Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
    Matthews DC; Badger CC; Fisher DR; Hui TE; Nourigat C; Appelbaum FR; Martin PJ; Bernstein ID
    Cancer Res; 1992 Mar; 52(5):1228-34. PubMed ID: 1531324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies.
    Badger CC; Krohn KA; Shulman H; Flournoy N; Bernstein ID
    Cancer Res; 1986 Dec; 46(12 Pt 1):6223-8. PubMed ID: 3779642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
    Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
    Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose radiolabeled antibody therapy of lymphoma.
    Bernstein ID; Eary JF; Badger CC; Press OW; Appelbaum FR; Martin PJ; Krohn KA; Nelp WB; Porter B; Fisher D
    Cancer Res; 1990 Feb; 50(3 Suppl):1017s-1021s. PubMed ID: 2297714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.
    Matthews DC; Appelbaum FR; Eary JF; Fisher DR; Durack LD; Bush SA; Hui TE; Martin PJ; Mitchell D; Press OW
    Blood; 1995 Feb; 85(4):1122-31. PubMed ID: 7849300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.
    Press OW; Eary JF; Appelbaum FR; Martin PJ; Badger CC; Nelp WB; Glenn S; Butchko G; Fisher D; Porter B
    N Engl J Med; 1993 Oct; 329(17):1219-24. PubMed ID: 7692295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.
    Buchsbaum DJ; Wahl RL; Glenn SD; Normolle DP; Kaminski MS
    Cancer Res; 1992 Feb; 52(3):637-42. PubMed ID: 1732052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of iodine-131-labeled anti-immune response-associated monoclonal antibody as preparative regimen prior to bone marrow transplantation: initial dosimetry.
    Appelbaum FR; Badger CC; Deeg HJ; Nelp WB; Storb R
    NCI Monogr; 1987; (3):67-71. PubMed ID: 3547145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
    Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE
    J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM; Motta-Hennessy C; Pawlyk D; Siegel JA; Goldenberg DM
    Cancer Res; 1990 Apr; 50(8):2330-6. PubMed ID: 2180566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of propylthiouracil on the biodistribution of an iodine-131-labeled anti-myeloid antibody in normal dogs: dosimetry and clinical implications.
    Bianco JA; Brown PA; Durack L; Badger C; Bernstein I; Eary J; Durham J; Fisher D; Sandmaier B; Schuening F
    J Nucl Med; 1990 Aug; 31(8):1384-9. PubMed ID: 2384808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy with intravenously administered 131I-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancer.
    van Zanten-Przybysz I; Molthoff CF; Roos JC; Plaizier MA; Visser GW; Pijpers R; Kenemans P; Verheijen RH
    J Nucl Med; 2000 Jul; 41(7):1168-76. PubMed ID: 10914906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.
    Scheinberg DA; Lovett D; Divgi CR; Graham MC; Berman E; Pentlow K; Feirt N; Finn RD; Clarkson BD; Gee TS
    J Clin Oncol; 1991 Mar; 9(3):478-90. PubMed ID: 1999719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
    Juweid ME; Stadtmauer E; Hajjar G; Sharkey RM; Suleiman S; Luger S; Swayne LC; Alavi A; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3292s-3303s. PubMed ID: 10541378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
    Korppi-Tommola ET; Kairemo KJ; Jekunen AP; Niskanen EO; Savolainen SE
    Acta Oncol; 1996; 35(3):357-65. PubMed ID: 8679267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
    J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen.
    Nourigat C; Badger CC; Bernstein ID
    J Natl Cancer Inst; 1990 Jan; 82(1):47-50. PubMed ID: 1967149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.